Lpath Incorporated

• Home
• About Lpath
  • Overview
  • Company Summary
  • Pipeline
  • Our Novel Approach
  • Patent Portfolio
  • Pioneers of the Category
• The Lpath Team
  • Executive Team
  • Board of Directors
  • Advisory Board
• The Science: An Overview
  • Technical Overview
  • Publications/Presentations/ Grants
• Investor Center
  • Investor Overview
  • Stock Information
  • News Releases
  • Calendar of Events
  • SEC Filings
  • Investor FAQ
  • Governance Documents
  • Request Information
  • Email Alerts
• Legal, Important Notices
• Contact Us

Investor Overview

Stock Quote LPTN (Common Stock ) Exchange NASDAQ CM (US Dollar) Price $4.58 Change (%)   0.01 (0.22%) Volume 8,500 Data as of 06/19/13 4:00 p.m. ET Minimum 20 minute delay Refresh quote
Recent News More >> Date Title   05/30/13 Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 05/23/13 Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP 04/16/13 Lpath Adds Two Key Members to its Executive Team 03/22/13 Lpath Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP Receive E-mail Alerts Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now! Quotes delayed at least 15 minutes. Market data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.